Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07199244 · ClinicalTrials.gov registry record · NA
The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females
A NA study of Anemia and Iron Deficiency (Without Anemia), sponsored by Nutraceuticals Research Institute.
- Active
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT07199244: Active NA study of Anemia and Iron Deficiency (Without Anemia), sponsored by Nutraceuticals Research Institute.
NCT07199244 is a NA study of Anemia and Iron Deficiency (Without Anemia) that is active but no longer recruiting, run by Nutraceuticals Research Institute. The registered enrollment target is 61 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07199244, a NA study of Anemia and Iron Deficiency (Without Anemia), is active but no longer recruiting, sponsored by Nutraceuticals Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to identify how well a fish-based iron supplement is absorbed and to learn how many, if any, digestive related side effects are caused by ingesting the supplement.
Primary Outcome
total iron measured through blood draws
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT marine-based heme iron
Study Locations (1)
Alabama
- Nutraceuticals Research Institute - Huntsville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2025-10 |
| Phase | NA |
What the registry record for NCT07199244 still lists
NCT07199244 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which marine-based heme iron is the first listed.
NCT07199244 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT07199244 about?
NCT07199244 is a clinical study titled "The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females". The goal of this study is to identify how well a fish-based iron supplement is absorbed and to learn how many, if any, digestive related side effects are caused by ingesting the supplement.
What is the current status of trial NCT07199244?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 61 participants. The study started on 2024-08-01. Estimated completion is 2025-10.
What conditions does trial NCT07199244 study?
This clinical trial studies the following conditions: Anemia, Iron Deficiency (Without Anemia), Iron Absorption.
What interventions are being tested in trial NCT07199244?
The interventions under investigation include: marine-based heme iron (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07199244?
This trial is sponsored by Nutraceuticals Research Institute, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07199244 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07199244's enrollment target sits among peer trials
61 53rd of 72 higher than 20 of 72 other Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
-
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
RECRUITING · NA
-
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
RECRUITING · NA
-
Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia
ACTIVE NOT RECRUITING · NA
-
Placental Transfusion in Term Infants: A Pilot Study
COMPLETED · NA
-
Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI